A Bayesian semiparametric joint hierarchical model for longitudinal and survival data.

This article proposes a new semiparametric Bayesian hierarchical model for the joint modeling of longitudinal and survival data. We relax the distributional assumptions for the longitudinal model using Dirichlet process priors on the parameters defining the longitudinal model. The resulting posterior distribution of the longitudinal parameters is free of parametric constraints, resulting in more robust estimates. This type of approach is becoming increasingly essential in many applications, such as HIV and cancer vaccine trials, where patients' responses are highly diverse and may not be easily modeled with known distributions. An example will be presented from a clinical trial of a cancer vaccine where the survival outcome is time to recurrence of a tumor. Immunologic measures believed to be predictive of tumor recurrence were taken repeatedly during follow-up. We will present an analysis of this data using our new semiparametric Bayesian hierarchical joint modeling methodology to determine the association of these longitudinal immunologic measures with time to tumor recurrence.

[1]  R. Prentice.  Covariate measurement errors and parameter estimation in a failure time regression model , 1982 .

[2]  Adrian F. M. Smith,et al.  Sampling-Based Approaches to Calculating Marginal Densities , 1990 .

[3]  M D Schluchter,et al.  Methods for the analysis of informatively censored longitudinal data. , 1992, Statistics in medicine.

[4]  M. Wulfsohn,et al.  The Relationship of CD4 Counts over Time to Survival in Patients with AIDS: Is CD4 a Good Surrogate Marker? , 1992 .

[5]  V. De Gruttola,et al.  Modelling progression of CD4-lymphocyte count and its relationship to survival time. , 1994, Biometrics.

[6]  M. Escobar.  Estimating Normal Means with a Dirichlet Process Prior , 1994 .

[7]  M. Wulfsohn,et al.  Modeling the Relationship of Survival to Longitudinal Data Measured with Error. Applications to Survival and CD4 Counts in Patients with AIDS , 1995 .

[8]  M. Escobar,et al.  Bayesian Density Estimation and Inference Using Mixtures , 1995 .

[9]  S. MacEachern,et al.  A semiparametric Bayesian model for randomised block designs , 1996 .

[10]  V. DeGruttola,et al.  Models for empirical Bayes estimators of longitudinal CD4 counts. , 1996, Statistics in medicine.

[11]  D. Thomas,et al.  Simultaneously modelling censored survival data and repeatedly measured covariates: a Gibbs sampling approach. , 1996, Statistics in medicine.

[12]  M. Wulfsohn,et al.  A joint model for survival and longitudinal data measured with error. , 1997, Biometrics.

[13]  S. MacEachern,et al.  Estimating mixture of dirichlet process models , 1998 .

[14]  Michael A. West,et al.  Computing Nonparametric Hierarchical Models , 1998 .

[15]  Joseph G. Ibrahim,et al.  Semiparametric Bayesian Methods for Random Effects Models , 1998 .

[16]  J G Ibrahim,et al.  A semiparametric Bayesian approach to the random effects model. , 1998, Biometrics.

[17]  Eric R. Ziegel,et al.  Practical Nonparametric and Semiparametric Bayesian Statistics , 1998, Technometrics.

[18]  Radford M. Neal.  Markov Chain Sampling Methods for Dirichlet Process Mixture Models , 2000 .

[19]  Yan Wang,et al.  Jointly Modeling Longitudinal and Event Time Data With Application to Acquired Immunodeficiency Syndrome , 2001 .

[20]  V. Sondak,et al.  High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  Joseph G. Ibrahim,et al.  BAYESIAN METHODS FOR JOINT MODELING OF LONGITUDINAL AND SURVIVAL DATA WITH APPLICATIONS TO CANCER VACCINE TRIALS , 2004 .

[22]  M. E. Galassi,et al.  GNU SCIENTI C LIBRARY REFERENCE MANUAL , 2005 .

[23]  D.,et al.  Regression Models and Life-Tables , 2022 .